Could INTELGENX TECHNOLOGIES CORP. Crash Even More? The Stock Had Another Big Decline Today

 Could INTELGENX TECHNOLOGIES CORP. Crash Even More? The Stock Had Another Big Decline Today

The stock of INTELGENX TECHNOLOGIES CORP. (CVE:IGX) is a huge mover today! About 18,000 shares traded hands or 437.15% up from the average. INTELGENX TECHNOLOGIES CORP. (CVE:IGX) has risen 6.00% since October 8, 2016 and is uptrending. It has outperformed by 4.04% the S&P500.
The move comes after 6 months negative chart setup for the $62.98 million company. It was reported on Nov, 7 by Barchart.com. We have $0.83 PT which if reached, will make CVE:IGX worth $8.82 million less.

More news for INTELGENX TECHNOLOGIES CORP. (CVE:IGX) were recently published by: Seekingalpha.com, which released: “The Ducks Are Lining Up For IntelGenx Bulls” on January 27, 2014. Seekingalpha.com‘s article titled: “IntelGenx- Maintaining Buy Rating” and published on November 12, 2015 is yet another important article.

IGX.V Company Profile

IntelGenx Technologies Corp. (IntelGenx), incorporated on July 27, 1999, is a drug delivery firm focusing on the development of orally administered drug delivery products based on its oral drug delivery technologies. The Firm is a well-known provider of product development services for the pharmaceutical industry, including the branded and generic pharmaceutical markets. The Company’s product development is based upon three delivery platform technologies: a Multilayer Tablet technology an Oral Film technology, and a Mucoadhesive Tablet technology. The Company’s Multilayer Tablet platform technology allows for the development of oral controlled-release products. The Oral Film technology allows for the instant delivery of pharmaceuticals to the oral cavity, and the Mucoadhesive Tablet allows for the controlled release of active substances to the oral mucosa.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Related posts

Leave a Comment